0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch china biosimilar monoclonal antibodies industry 2016 market research report.Your search for "" gave back 1526912 results.
Summary The global Oncology Biosimilars market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define,...
Catalog:
HYR
September 2021
Price: USD 1,800.00
The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and...
Catalog:
iGATE
October 2016
Price: USD 1,350.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Biosimilar Monoclonal Antibody market size was valued at US$ 4411.1 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Biosimilar Monoclonal Antibodies market size was valued at US$ 4411.1 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biosimilar Monoclonal Antibodies market size was valued at USD 4639.7 million in 2023 and is forecast to a readjusted size of USD 12580...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Omalizumab monoclonal antibody biosimilar is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
